Biomedicine & Pharmacotherapy

The impact of quetiapine on the brain lipidome in a cuprizone-induced mouse model of schizophrenia

Publication date: November 2020Source: Biomedicine & Pharmacotherapy, Volume 131Author(s): Cui-hong Zhou, Shan-shan Xue, Fen Xue, Ling Liu, Jun-chang Liu, Quan-rui Ma, Jun-hui Qin, Qing-rong Tan, Hua-ning Wang, Zheng-wu Peng

Biomedicine & Pharmacotherapy

Mon Sep 07, 2020 14:04

Effects of galloflavin and ellagic acid on sirtuin 6 and its anti-tumorigenic activities

Publication date: November 2020Source: Biomedicine & Pharmacotherapy, Volume 131Author(s): Minna Rahnasto-Rilla, Joni Järvenpää, Marjo Huovinen, Anna-Mari Schroderus, Emmi-Leena Ihantola, Jenni Küblbeck, Mohammed Khadeer, Ruin Moaddel, Maija Lahtela-Kakkonen

Biomedicine & Pharmacotherapy

Mon Sep 07, 2020 14:04

Mark above section as read

 Brachytherapy

Characterization and registration of 3D ultrasound for use in permanent breast seed implant brachytherapy treatment planning

Publication date: Available online 6 September 2020Source: BrachytherapyAuthor(s): Claire Zhang, Michelle Hilts, Deidre Batchelar, Nathan Orlando, Lori Gardi, Aaron Fenster, Juanita Crook

Brachytherapy

Mon Sep 07, 2020 19:44

Mark above section as read

 Clinical Therapeutics

Different Coagulation Indicators in Predicting Clinical Outcomes for Patients With Direct Oral Anticoagulants: A Systematic Review and Meta-analysis

Publication date: Available online 6 September 2020Source: Clinical TherapeuticsAuthor(s): Zhiyan Liu, Hanxu Zhang, Qiufen Xie, Guangyan Mu, Shuang Zhou, Zining Wang, Zhe Wang, Jie Jiang, Qian Xiang, Yimin Cui

Clinical Therapeutics

Mon Sep 07, 2020 20:25

Pharmacokinetic and Glucodynamic Responses of Ultra Rapid Lispro (URLi) vs Lispro (Humalog®) Across a Clinically Relevant Range of Subcutaneous Doses in Healthy Subjects

Publication date: Available online 6 September 2020Source: Clinical TherapeuticsAuthor(s): Jennifer Leohr, Mary Anne Dellva, Elizabeth LaBell, David E. Coutant, Oliver Klein, Leona Plum-Moerschel, Eric Zijlstra, Helle Linnebjerg

Clinical Therapeutics

Mon Sep 07, 2020 20:25

Mark above section as read

 Latest Results for Investigational New Drugs

Correction to: Phase 1 dose-escalation study of a novel oral PI3K/mTOR dual inhibitor, LY3023414, in patients with cancer

The article Phase 1 dose-escalation study of a novel oral PI3K/mTOR dual inhibitor, LY3023414, in patients with cancer, written by Shunsuke Kondo, Masaomi Tajimi, Tomohiko Funai, Koichi Inoue, Hiroya Asou, Vinay Kumar Ranka, Volker Wacheck, Toshihiko Doi, was originally published electronically on the publisher’s internet portal on 23 June 2020 without open access.

Latest Results for Investigational New Drugs

Mon Sep 07, 2020 03:00

Mark above section as read

 ScienceDirect Publication: International Immunopharmacology

Long term inhibition of hip joint damage under tumor necrosis factor-alpha inhibitors in spondyloarthritis

Publication date: November 2020Source: International Immunopharmacology, Volume 88Author(s): Ines Mahmoud, Kaouther Maatallah, Dorra Ben Nessib, Safa Belghali, Kawther Ben Abdelghani, Leila Metoui, Olfa Saidane, Wafa Hamdi, Bechir Zouari, Kamel Ben Salem, Rawdha Tekaya, Leila Abdelmoula

ScienceDirect Publication: International Immunopharmacology

Mon Sep 07, 2020 18:21

The therapeutic potential of resveratrol in a mouse model of melanoma lung metastasis

Publication date: November 2020Source: International Immunopharmacology, Volume 88Author(s): Amirhossein Davoodvandi, Maryam Darvish, Sarina Borran, Majid Nejati, Samaneh Mazaheri, Omid Reza Tamtaji, Micheal R. Hamblin, Nahid Masoudian, Hamed Mirzaei

ScienceDirect Publication: International Immunopharmacology

Mon Sep 07, 2020 18:21

Mark above section as read